Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

ClinicalTrials.gov ID: NCT04513912

Public ClinicalTrials.gov record NCT04513912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Randomized, Parallel-Group Study With Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy of seltorexant compared with quetiapine extended-release (XR) as adjunctive therapy to an antidepressant drug in treatment response in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).

Study identification

NCT ID
NCT04513912
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
757 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2020 (Actual)
Primary completion
Oct 3, 2023 (Actual)
Completion
Oct 3, 2023 (Actual)
Last update posted
Aug 13, 2025

2020 – 2023

United States locations

U.S. sites
75
U.S. states
24
U.S. cities
65
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
SW Biomedical Research LLC Tucson Arizona 85712 —
Proscience Research Group Culver City California 90230 —
Pharmacology Research Institute Encino California 91316 —
Collaborative NeuroScience Network Garden Grove California 92845 —
Collaborative NeuroScience Network Long Beach California 90806 —
Pharmacology Research Institute Los Alamitos California 90720 —
CalNeuro Research Los Angeles California 90025 —
Pharmacology Research Institute Newport Beach California 92660 —
NRC Research Institute Orange California 92868 —
Pacific Neuropsychiatric Specialists Orange California 92868 —
CNRI-Los Angeles, LLC Pico Rivera California 90660 —
Prospective Research Innovations Inc Rancho Cucamonga California 91730 —
Anderson Clinical Research Redlands California 92374 —
University of California at San Diego San Diego California 92103 —
National Research Institute Santa Ana California 91704 —
CI Trials Santa Ana California 92705 —
CMB Clinical Trials Santee California 92071 —
Schuster Medical Research Institute Sherman Oaks California 91403 —
Pacific Clinical Research Medical Group Upland California 91786 —
Hartford Hospital Hartford Connecticut 06102 —
Moonshine Research Center, Inc Doral Florida 33166 —
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009 —
Indago Research & Health Center Inc Hialeah Florida 33012 —
New Life Medical Research Center, Inc. Hialeah Florida 33012 —
Amedica Research Institute Inc Hialeah Florida 33013 —
Meridien Research Lakeland Florida 33803 —
Premier Clinical Research Miami Florida 33122 —
Global Medical Institutes Miami Florida 33125 —
Miami Jewish Health System Miami Florida 33137 —
Clinical Neuroscience Solutions Orlando Florida 23801 —
Synexus Research Orlando Orlando Florida 32806 —
University of South Florida Tampa Florida 33612 —
Compass Research LLC-Bioclinica Research The Villages Florida 32162 —
Synexus Clinical Research US Inc Atlanta Georgia 30328 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
iResearch Atlanta LLC Decatur Georgia 30030 —
Psych Atlanta, P.C. Marietta Georgia 30060 —
Chicago Research Center Chicago Illinois 60634 —
Capstone Clinical Research Libertyville Illinois 60048 —
Alexian Brothers Health System Lisle Illinois 60532 —
Baber Research Group Naperville Illinois 60563 —
Lemah Creek Clinical Research Oakbrook Terrace Illinois 60618 —
Ascension via Christi Research Wichita Kansas 67214 —
Riverstar Research New Orleans Louisiana 70115 —
Pharmasite Research, Inc. Baltimore Maryland 21208 —
BTC of New Bedford New Bedford Massachusetts 02740 —
Boston Clinical Trials & Medical Research Roslindale Massachusetts 02135 —
Psychiatric Care and Research Center (PCRC) O'Fallon Missouri 63368 —
Bio Behavioral Health Toms River New Jersey 08755 —
SPRI Clinical Trials, LLC Brooklyn New York 11235 —
Fieve Clinical Research Inc New York New York 10017 —
The Medical Research Network, LLC New York New York 10128 —
Finger Lakes Clinical Research Rochester New York 14618 1609 —
Richmond Behavioral Associates Staten Island New York 10312 —
Velocity Clinical Research, Inc. Durham North Carolina 27701 —
University of Cincinnati, Dept of Psychiatry & Behavioral Neuroscience Cincinnati Ohio 45219 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Neuro Behavioral Clinical Research North Canton Ohio 44720 —
Sooner Clinical Research Oklahoma City Oklahoma 73112 —
Paradigm Research Professionals, LLC Oklahoma City Oklahoma 73118 —
Suburban Research Associates Pine Hill Pennsylvania 08021 —
Global Medical Institutes Scranton Pennsylvania 18503 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
West Houston Clinical Research Service Bellaire Texas 77401 —
North Texas Clinical Trials Fort Worth Texas 76104 —
Hawkins Psychiatry, PC Mansfield Texas 76054 —
Family Psychiatry of The Woodlands The Woodlands Texas 77381 —
Grayline Research Center Wichita Falls Texas 76309 —
Alpine Research Organization Clinton Utah 84015 —
Cedar Clinical Research Draper Utah 84020 —
University of Virginia Charlottesville Virginia 22903 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Core Clinical Research Everett Washington 98201 —
Cary J. Kohlenberg, MD, SC, dba, IPC Research. Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04513912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04513912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →